Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Lactulose.
A synthetic disaccharide acting as an osmotic laxative and prebiotic that acidifies the colonic environment to facilitate the conversion of ammonia to non-absorbable ammonium ions, primarily used in treating chronic constipation and hepatic encephalopathy.
11333
342.30 g/mol
-4.3
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Lactulose across standard consumer modalities.
Lactulose is highly hygroscopic and typically requires high dosages (grams), making standard size 0 or 00 capsules impractical for therapeutic efficacy.
The high sugar-like mass required for a therapeutic dose can interfere with pectin gelation and significantly increase the caloric density of the delivery format.
The high therapeutic dose requirement (often >10g) far exceeds the typical 50-100mg payload capacity of thin-film oral strip matrices.
Ready to launch a product featuring Lactulose? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Lactulose extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Lactulose payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation